Effect of comorbidities on outcomes and ivabradine effects in patients with chronic systolic heart failure in the SHIFT trial

被引:0
|
作者
Bohm, Servier M. [1 ]
Borer, J. S. [2 ]
Ford, I. [3 ]
Lainscak, M. [4 ]
Komajda, M. [5 ]
Robertson, M. [3 ]
Tavazzi, L. [6 ]
Swedberg, K. [7 ]
机构
[1] Univ Saarlandes Kliniken, Innere Med Klin 3, Homburg, Germany
[2] Suny Downstate Med Ctr, New York, NY USA
[3] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[4] Gen Hosp Celje, Dept Cardiol, Celje, Slovenia
[5] Univ Paris 06, La Pitie Salpetriere Hosp, Dept Cardiol, Paris, France
[6] Ettore Sansavini Hlth Sci Fdn, Maria Cecilia Hosp GVM Care & Res, Cotignola, Italy
[7] Univ Gothenbur, Sahlgrenska Acad, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1283
引用
收藏
页码:266 / 266
页数:1
相关论文
共 50 条
  • [1] Effect of Comorbidities and Risk Factors on Outcomes and Ivabradine's Effects in Patients With Chronic Systolic Heart Failure in the SHIFT Trial
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Komajda, Michel
    Robertson, Michele
    Tavazzi, Luigi
    Swedberg, Karl
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S46 - S46
  • [2] Ivabradine in Heart Failure The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure
    Das, Debraj
    Savarese, Gianluigi
    Dahlstrom, Ulf
    Fu, Michael
    Howlett, Jonathan
    Ezekowitz, Justin A.
    Lund, Lars H.
    [J]. CIRCULATION-HEART FAILURE, 2017, 10 (09)
  • [3] Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
    Borer, Jeffrey S.
    Boehm, Michael
    Ford, Ian
    Komajda, Michel
    Tavazzi, Luigi
    Lopez Sendon, Jose
    Alings, Marco
    Lopez-de-Sa, Esteban
    Swedberg, Karl
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (22) : 2813 - 2820
  • [4] Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial
    Boehm, Michael
    Robertson, Michele
    Borer, Jeffrey
    Ford, Ian
    Komajda, Michel
    Mahfoud, Felix
    Ewen, Sebastian
    Swedberg, Karl
    Tavazzi, Luigi
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [5] Efficacy and safety of ivabradine in patients with chronic systolic heart failure and low blood pressure in the shift trial
    Komajda, M.
    Bohm, M.
    Borer, J.
    Ford, I.
    Robertson, M.
    Manolis, A.
    Tavazzi, L.
    Swedberg, K.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 610 - 610
  • [6] Efficacy and Safety of Ivabradine in Patients with Chronic Systolic Heart Failure and Low Blood Pressure in the SHIFT Trial
    Komajda, Michel
    Bohm, Michael
    Borer, Jeff
    Ford, Ian
    Robertson, Michele
    Manolis, Athanasios
    Tavazzi, Luigi
    Swedberg, Karl
    [J]. JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) : S38 - S38
  • [7] Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
    Komajda, Michel
    Tavazzi, Luigi
    Francq, Bernard G.
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Swedberg, Karl
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (12) : 1294 - 1301
  • [8] Ivabradine effect on outcomes in patients with systolic heart failure according to the duration of their disease: analysis from SHIFT
    Bohm, M.
    Swedberg, K.
    Komajda, M.
    Tavazzi, L.
    Borer, J. S.
    Moyne, A.
    Ford, I.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 225 - 225
  • [9] Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: The SHIFT trial analysis
    Lainscak, Mitja
    Tavazzi, Luigi
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffrey
    Robertson, Michele
    Ford, Ian
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/left ventricular dysfunction in the SHIFT trial
    Borer, J. S.
    Bohm, M.
    Ford, I.
    Komajda, M.
    Tavazzi, L.
    Swedberg, K.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S151 - S151